Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The Auscann Group Holdings Ltd (ASX: AC8) share price has continued its strong run and is up a further 6% to 46 cents today.
This means the medicinal cannabis company’s shares have jumped over 20% since this time last week.
Why has it jumped?
The rally in AusCann’s shares can be traced back to June 15 when the company announced the key appointment of Dr Danial Schecter as Chief Medical Advisor.
Since the day of this announcement, AusCann’s shares have climbed in excess of 30%.
Investors appear to be optimistic that the appointment of the international medical cannabis expert will help the company succeed in its medical outreach program.
The company aims for the program to educate Australian physicians about the benefits of medicinal cannabis, ultimately allowing them to make an informed decision on whether or how to prescribe cannabinoid medicines.
16% increase today on volume over 50,000.... hoping it's the start of something, might just be other retail getting in early on the game. Give it a few years and we should be over a dollar easily, Auscann is an Australian company that will make it im sure.
The shorts appear to be gone:
AUSCANN GROUP HOLDINGS LTD ORD AUST (OTCMKTS:ACNNF) Short Interest Decreased By 92.14%
May 26, 2017 - By Maria Brooks
The stock of AUSCANN GROUP HOLDINGS LTD ORD AUST (OTCMKTS:ACNNF) registered a decrease of 92.14% in short interest. ACNNF’s total short interest was 26,100 shares in May as published by FINRA. Its down 92.14% from 332,000 shares, reported previously. With 179,000 shares average volume, it will take short sellers 0 days to cover their ACNNF’s short positions.
pay raise for what, are there any revenues yet?
LOOKS LIKE AC8 IS GETTING SOME HELP FROM CANOPY/TWEED....Appointment of Chief Medical Advisor
AusCann is delighted to announce the appointment of prominent Canadian doctor and medical cannabis expert Dr Danial Schecter as its Chief Medical Advisor.
Dr Schecter brings comprehensive knowledge of medical cannabis in practical clinical use. He has worked extensively within the field, having founded the largest referral only clinic in Canada that specialises in cannabinoid medicine.
Doctor training and awareness forms a key part of the Company’s strategy to educate the medical community on the potential benefits of cannabinoids as therapeutic agents to treat certain conditions, such as chronic pain and Dr Schecter will provide clinical guidance, support and education to the doctor community.
AusCann and Dr Schecter recently hosted a number of educational seminars in Sydney Brisbane and Perth as part of its Medical Outreach Program, which received an overwhelmingly positive response from Australian doctors.
Let's hope so, last I heard from the company is that they were in Asia looking for some more new investors. As one of the top companies in the Australian space, along with canopy by its side, in sure this is nothing more than just a long wait until some profits.
We should have revenue before 2017 ends and that'll give it a nice bump, then expansion early 2018, some profits mid to late 2018 then hopefully exports by 2019, by which time I'm hoping it's hit over $2usd.
It it gets anywhere near $4usd before then though, I'll take my money and retire.
Nice 15% bounce, much needed
Today is a better day for Australian stocks in general. Zelda making back some gains and Auscann too. I'll still be here in 2-3 years though, waiting for that $2-4 range usd
You know that saying "hogs get fat, pigs get slaughtered"
You know that saying "hogs get fat, pigs get slaughtered"
surprising how far these types trace back..I was so up now so down..duh...gaps suck..!
Whisper is quietly, but, we may just have found a floor. At .40aud ( .30usd) That's where I see some support at least.
They're looking at getting a few new private investors, hopefully not more dilution (I wouldn't suspect not after the recent 12m raising) but we will see.
Up a few% down under, let's hope they close the day out green, another few to end the week on a green NOT and it may be reversal time. That's the optimist in me at least.
I think we can ride this out. Im in at .60usd and if it hits .17 again I think I'll just add until I've averaged down below .50
Long term I think this will be one of the Australian companies that make it, along will cann group.
I have some Zelda and MGC Parma but that's more speculative.
Auscann is of course speculative in itself but given the management plus experience canopy brings to the table (they are the major shareholder and voluntarily tied up their shares for 3 years) coupled with the possibility of exports to Asia and the near certainty that at least domestically they'll be a major producer, I believe we have a solid company.
Dilution is never nice but as long as they actually use those funds for smart expansion then I'm not concerned long term. It just hurts to be at a 50% paper loss currently.
More what? Gaps. It debuted on the US market at .17
many times it does only get close...depending...aren't there more...?
It's all a guess at this point the excitement of weed has pretty much gone up in smoke lately. I'm fairly confident this hits .17 within a couple weeks and then I'll buy back in. Two years seems like ample time to get to a dollar as long as they don't keep diluting which they just did a couple weeks back and they have to perform. I won't be surprised if it hits. 17 then slowly climbs back into the .50 cent range and just hangs out there for several months.
So short term it's F***** but what's the long term outlook?
2 years to be over $1usd? Seem reasonable?
It broke .34 aussie equivalent tonight. There's a few days of support around .26 - .28 but not much. If it gets to .26 it will definitely go to .17. It's not going to get that close to a gap without filling it.
many time gaps are confusing but often are the start of a substantial run and going back to close it would be way too much weakness when the opposite is what is happening...if it were to close it then often over shoots and any strength is gone unless it is very quick dip and gets over last high relatively quickly...
Can't say for sure that it will get to .17 but the odds are in favor of it. It's filled just about every gap it made and there are no real catalysts on the near horizon that I know of. Look at CGC that's filled every gap it made so far although I haven't looked at a chart lately of it to see if there were any gaps under $5 US. Do I think Auscann will get to $4? I don't think any time soon as in the next few to several years. All the excitement for the weed market has seemed to disappear. If the you never paid attention to that old saying buy the rumor sell the news the entire weed market was a glaring example of that. Still can't believe it myself that it dropped after release of regulations. If Auscann can stay up for several days in a row then I think it's safe to say it won't fill the .17 gap. I won't be a buyer again until I see evidence of some stability in the price or that it's still dropping. If it drops then .17 is the floor.
You think it'll go all the way back to IPO levels? 0.17 cents for a gap... that'd be very low indeed, yes a lot of gaps get filled but that would be quite something considering the progression made since march, expansion and joint ventures.
Think it'll ever get to $4 usd? That's where I want to sell anytime within the next 3 years.
Up 6.5% in Aussie land now, definitely an interesting play we have here
Out, sold my entire position today. Had my goal set that I wasn't going to go below a double on this. Certainly in hindsight wished I had dumped at .70 for a 15K gain but I settled for 5k. I'll buy back in when and if it gets close to .17 cents. There's a huge gap at .17 and statistically 85% of all gaps get filled. That said I have an 85% chance of getting back in at where I originally bought in.
Another article I think some might have missed.
http://www.ibtimes.com.au/cannabis-now-being-used-treat-severe-drug-addiction-medical-marijuana-company-auscann-ready-expand
Below 0.40 USD is a STEAL!! I can't believe I'm out of powder right now. But yes, low volume, MM's making it cheaper and shaking a tree and all that. Quite concerning next few months ahead but the share price should be closer to $1 by Christmas.
Just loaded up some more at about the same price the institutional investors were getting theirs at (at their discounted price).
This should move up from here (I hope). Can't see any good reason for it to go down any lower, other than some downward momentum, that's hopefully about over.
agreed, my point is that we need some news to kickstart the stock again.
Of course we need revenues. But it's been less than a month since they got their license to grow demostically, then there's R&D education to doctors and to patients, advertisarion for the products. Then you've got to remember that maybe in a few years Australia will legalize just like Canada and parts of the US have (and likely to be federally within a few years) then other western countries followed by Asia (where Australia would be the easier and cheapest import location and has A LOT of sun so the capacity for AMAZING cannabis) in looking at Auscann as possibly a 3-5 year investment; perhaps even 10 years if my 'perfect world' comes to any sort of fruition. I truely believe $4 usd is strongly possible within the 3-5 year timeframe and then optimistically (and in my daydreams) I would hope for $7.50-$9 USD as a perfect sell point.
Now it is .49, we need some revenues to generate confidence in the company
Down 9% in Australia to 0.52 AUD, capital raising at 0.50 looks like it's having its effect today, shouldn't be a problem however as it's for growth and expansion, plus the new joint venture and mix in that it's still completely in its infancy and the % swings shouldn't be too scary, very annoying as I averaged down a week or so back and could have a few more thousand shares if I'd waited until today.
May even sell some shares in other companies I hold to get a little more exposure to Auscann. Lots of risk but I see a very high payoff down the road. My very minimal target for 1 year would be $1 usd, basically when they're harvesting multiple crops domestically.
Still could go the other way I'm sure, but I think Auscann is a solid company, especially if CGC is happy to have their shares tied up for 3 years.
So much for all the naysayers, stating ... this would be a bad move. Lol
Go AusCann!!!!
JAX
Institutional investors feel good about this company, and so do I.
And one more article about Tasmanian Alkaloids with Auscann:
http://www.themercury.com.au/lifestyle/poppy-grower-tasmanian-alkaloids-to-expand-into-medicinal-cannabis-in-jointventure-deal-with-auscann/news-story/3d81c4a026307cf046ed866c769cc171
Auscann teaming up with Tasmanian Alkaloids:
http://www.proactiveinvestors.com.au/companies/news/177879/auscann-group-holdings-partners-with-tasmanian-alkaloids-177879.html
Pretty good opening after the partnership announcement even after the capital raising as well, looks to me like expansion and some smart partnering for execution.
Let's hope it can be 'the canopy of australia' and all ride it up over $10 a share!! (Probably a long way off, well over a year to get to those levels, but who knows, could be a massive hype one day and have a sudden pop)
Medical cannabis group AusCann is in the market today raising $10 million to fund a joint venture with a global partner, TasAlk.
Merchant Corporate Advisory is the lead manager and sole bookrunner for the deal which could be increased if there is investor demand.
A term sheet seen by DataRoom shows a share placement will be carried out at 50c a share, compared to AusCann’s (AC8) closing price of 58c.
The funds will be used to grow and manufacture medicinal cannabis under a new partnership with TasAlk, a global opiate ingredient manufacturer for pain medicine.
TasAlk already has some operations in Australia and the funds today will also help AusCann roll out its Australian doctors training program. The doctors will be trained in how to use the medicinal cannabis for pain control and palliative care. “The pain market in Australia for medical cannabis is expected to be substantial,” the term sheet says.
I Agee 100% we have already two established growers with a wealth of experience as well as all the connections Tasmanian Alkaloids have currently in the pipeline. Being an established global player in the pharmaceutical space will open a lot of eyes moving forward. Nice Job AusCann keep stoking that fire!
And yes this is all good indeed!!!!$$$$$
JAX
Awww really? That means they are introducing more shares? So drop in share price.?
It's raising capital not the kind of halt we want
http://mobile.reuters.com/article/idUSFWN1II0TX
Followers
|
38
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1484
|
Created
|
02/13/17
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |